Subscribe to Newsletter

April 2021 Issue of The Medicine Maker

Our 2021 Power List celebrates the inspirational individuals driving change across the pharma industry in three categories: Small Molecules, Biopharmaceuticals, and Advanced Medicine. Meanwhile, in NextGen, Jonathan Rhone, CEO at Axine Water Technologies, outlines the challenges caused by APIs in water and walk us through the technologies that enable their removal. We also round up the latest cell and gene therapy news and catch up with Johannes Khinast, who tells the story behind the Research Center for Pharmaceutical Engineering and how the organization has evolved over time.

Register to download
Register here to download any issue of The Medicine Maker for FREE.
Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Regulation Standards & Regulation

A Roadmap for Access

| Craig Burton

Craig Burton from the AAM says patients must be able to access generics and biosimilars.

Discovery & Development Drug Discovery

A Little Less Conventional

| Maryam Mahdi

Is there a place for traditional medicines in the pharmaceutical industry?

Business & Regulation Quality & Compliance

The Whey of Things

| Maryam Mahdi

New guidance on the use of whey and lactose-derived products in pharmaceuticals.

Discovery & Development Clinical Trials

Protecting the Vulnerable

| Maryam Mahdi

A trial sets out to explore the effects of various COVID-19 vaccines on vulnerable patients.

Manufacture Bioprocessing - Upstream & Downstream

Lowering Chromatography Costs

| Maryam Mahdi

A 70-year-old technique is helping to cut the development costs of monoclonal antibodies.

Business & Regulation Business Practice

In Silico Insight

| Maryam Mahdi

How can pharma use synthetic data to enhance clinical trials?

Manufacture Contract Manufacturing Services

Fit for the Future

| Stephanie Vine

We catch up with Samsung Biologics about easing tech transfers and preparing plants for the future.

Manufacture Advanced Medicine

What’s in Your Capsids?

| Lori Stansberry

Are your capsids full, half full, or empty? We need better analytical techniques to find out.

Business & Regulation Digital Technologies

Jumping into the Digital World

| Jason Lacombe

The pharma industry can no longer sit on the sidelines when it comes to digitization.

Manufacture Advanced Medicine

Riding the (Nucleo)Tidal Wave

| Karen Fallen

DNA manufacturers must pick up the pace to support the genetic medicine revolution.

Manufacture Bioprocessing - Upstream & Downstream

Filling: How to Find the Right Setup

| Robert Linder

Schott explains how ready-to-use containers can improve total costs of ownership for pharma companies.

Business & Regulation Advanced Medicine

The 2021 Power List is Out

We reveal The Medicine Maker 2021 Power List!

Manufacture Packaging

Raising the Bar(code)

| Stephanie Vine

How adding barcodes to glass containers can improve traceability.

Manufacture Facilities

A Smaller Piece of PiE

| Jonathan Rhone

Let’s reduce the impact of pharmaceutical effluent on the environment.

Discovery & Development Advanced Medicine

Hello World!

| James Strachan

CRISPR and bioengineering are hot topics from our Cell + Gene Curator roundup.

Manufacture Small Molecules

The Only Science Is Good Science

We interview Johannes Khinast, CEO and Scientific Director of the Research Center for Pharmaceutical Engineering (RCPE), Graz, Austria.

Other issues of 2021